We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Closed Infusion System Reduces Infection

By HospiMedica staff writers
Posted on 18 Jan 2006
A closed central intravenous infusion system can cut by more than half the rate of catheter-associated bloodstream infection compared to an open system. More...


These were the results of a study that evaluated 1,012 intensive care unit (ICU) patients with central venous catheters. The trial enrolled adults admitted to three tertiary-care ICUs in Brazil who had a central venous catheter in place for at least 24 hours. Rates of infection per 1,000 central venous catheter days were 7.1 during the open phase and 3.2 during the closed phase. The researchers concluded that the risk for getting central venous catheter infection was more than half that of the closed system than with the open system.

These findings were presented at the 45th annual Interscience Conference on Antimicrobial Agents and Chemotherapy, held in December 2005 in Washington (DC, USA).

The investigators calculated the rates of catheter-associated bloodstream infection during two time periods. In the active surveillance phase, the hospital used an open system, characterized by semi-rigid plastic bottles that had one port and were externally vented semi-rigid plastic bottles. In the second phase, the hospital switched to a closed system, which consisted of collapsible plastic bags that had two ports and were not vented.

"Adoption of a closed infusion system resulted in a 54% reduction in the rate of central venous catheter-associated bloodstream infections,” said principal investigator Reinaldo Salomao, M.D., Ph.D, chief of infectious and parasitic diseases at Hospital Santa Marcelina (Sao Paulo, Brazil).

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Mammo DR Retrofit Solution
DR Retrofit Mammography
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.